Clinical Trial: Phase I Clinical Trials Investigating the Potential Efficacy of Axitinib in Patients With a BRCA 1/2 Mutations
Study Status: ENROLLING_BY_INVITATION
Recruit Status: ENROLLING_BY_INVITATION
Condition: Breast Cancer
Study Type: INTERVENTIONAL
Official Title: Phase I Clinical Trials Investigating the Potential Efficacy of Axitinib in Patients With a BRCA 1/2 Mutations Independent of HER2 Expression With Progression After Previous Treatment
Brief Summary:
This Clinical Trial is investigating the potential efficacy of axitinib after genetic testing in BRCA 1/2 Mutation patients, regardless of HER2 expression, who have progressed after at least one line of standard treatment or for whom there is no consensus treatment approach.The use of Axitinib may help physicians plan for more effective patient care in combination with existing treatment protocols.
Read more